Jardy Tab 10MG

Medicine

Jardy Tab 10MG

Tab 10


Detail Description

Empagliflozin is an inhibitor of SGLT2. By inhibiting SGLT2, empagliflozin reduces renal reabsorption of filtered glucose and lowers the renal threshold for glucose, and thereby increases urinary glucose excretion. After oral administration, peak plasma concentrations of empagliflozin reached at 1.5 hours.

DISCLAIMER

The information provided on this website is not intended or implied to substitute for professional medical advice, diagnosis, or treatment. All content, including text, graphics, images, and other materials available on or through this website, is for general informational purposes only. Community Healthcare Clinics makes no representations and assumes no responsibility for the accuracy or completeness of the information provided on this site, which may be subject to change without notice. Users are strongly encouraged to verify any information obtained from this website with other reliable sources and consult with their physician or healthcare provider regarding any medical condition or treatment.
Do not disregard professional medical advice or delay seeking medical care because of information accessed through this website. Community Healthcare Clinics is not responsible or liable for any advice, treatment, diagnosis, or other information, services, or products obtained through this site.